IRadimed (IRMD) Revenue & Revenue Breakdown
IRadimed Revenue Highlights
Latest Revenue (Y)
$65.56M
Latest Revenue (Q)
$17.93M
Main Segment (Y)
MRI Compatible Patient Vital Signs Monitoring Systems
Main Geography (Y)
UNITED STATES
IRadimed Revenue by Period
IRadimed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $65.56M | 23.00% |
| 2022-12-31 | $53.30M | 27.48% |
| 2021-12-31 | $41.81M | 31.83% |
| 2020-12-31 | $31.72M | -17.65% |
| 2019-12-31 | $38.52M | 26.54% |
| 2018-12-31 | $30.44M | 31.88% |
| 2017-12-31 | $23.08M | -28.97% |
| 2016-12-31 | $32.50M | 2.86% |
| 2015-12-31 | $31.59M | 101.84% |
| 2014-12-31 | $15.65M | 38.03% |
| 2013-12-31 | $11.34M | 47.56% |
| 2012-12-31 | $7.69M | - |
IRadimed generated $65.56M in revenue during NA 2023, up 23.00% compared to the previous quarter, and up 215.39% compared to the same period a year ago.
IRadimed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $17.93M | 1.88% |
| 2024-03-31 | $17.60M | 0.84% |
| 2023-12-31 | $17.45M | 5.74% |
| 2023-09-30 | $16.50M | 2.32% |
| 2023-06-30 | $16.13M | 4.23% |
| 2023-03-31 | $15.48M | 4.11% |
| 2022-12-31 | $14.86M | 10.86% |
| 2022-09-30 | $13.41M | 5.39% |
| 2022-06-30 | $12.72M | 3.34% |
| 2022-03-31 | $12.31M | 3.69% |
| 2021-12-31 | $11.87M | 8.85% |
| 2021-09-30 | $10.91M | 11.18% |
| 2021-06-30 | $9.81M | 6.36% |
| 2021-03-31 | $9.22M | 7.93% |
| 2020-12-31 | $8.55M | 11.00% |
| 2020-09-30 | $7.70M | 13.31% |
| 2020-06-30 | $6.79M | -21.70% |
| 2020-03-31 | $8.68M | -20.32% |
| 2019-12-31 | $10.89M | 9.31% |
| 2019-09-30 | $9.96M | 8.00% |
| 2019-06-30 | $9.23M | 9.34% |
| 2019-03-31 | $8.44M | 1.18% |
| 2018-12-31 | $8.34M | 9.52% |
| 2018-09-30 | $7.61M | 3.22% |
| 2018-06-30 | $7.38M | 3.78% |
| 2018-03-31 | $7.11M | 6.01% |
| 2017-12-31 | $6.70M | 17.84% |
| 2017-09-30 | $5.69M | 2.99% |
| 2017-06-30 | $5.52M | 7.01% |
| 2017-03-31 | $5.16M | -13.82% |
| 2016-12-31 | $5.99M | -21.93% |
| 2016-09-30 | $7.67M | -22.25% |
| 2016-06-30 | $9.87M | 10.09% |
| 2016-03-31 | $8.96M | 1.87% |
| 2015-12-31 | $8.80M | 7.39% |
| 2015-09-30 | $8.19M | 7.68% |
| 2015-06-30 | $7.61M | 8.83% |
| 2015-03-31 | $6.99M | 95.11% |
| 2014-12-31 | $3.58M | -5.99% |
| 2014-09-30 | $3.81M | -18.90% |
| 2014-06-30 | $4.70M | 32.14% |
| 2014-03-31 | $3.56M | 2.90% |
| 2013-12-31 | $3.46M | 39.41% |
| 2013-09-30 | $2.48M | -10.64% |
| 2013-06-30 | $2.78M | 5.58% |
| 2013-03-31 | $2.63M | - |
IRadimed generated $17.93M in revenue during Q2 2024, up 1.88% compared to the previous quarter, and up 115.86% compared to the same period a year ago.
IRadimed Revenue Breakdown
IRadimed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| MRI Compatible Patient Vital Signs Monitoring Systems | $25.41M | $21.72M | - | - | - |
| MRI compatible IV infusion pump system | - | - | $13.29M | - | - |
| MRI compatible patient vital signs monitoring systems | - | - | $13.78M | - | - |
| M R I Compatible I V Infusion Pumps | - | - | - | $9.36M | $18.05M |
| Mri Compatible Patient Vital Signs Monitoring Systems | - | - | - | $9.76M | $9.71M |
IRadimed's latest annual revenue breakdown by segment (product or service), as of Dec 23: MRI Compatible Patient Vital Signs Monitoring Systems (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI Compatible Patient Vital Signs Monitoring Systems | $5.45M | $6.46M | $14.59M | $6.13M | $4.70M | $6.09M | $5.52M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| MRI compatible IV infusion pump system | - | - | - | - | - | - | - | $3.85M | $3.28M | $3.96M | - | - | - | - | - | - | - | - | - | - |
| MRI compatible patient vital signs monitoring systems | - | - | - | - | - | - | - | $4.92M | $5.19M | $4.02M | - | - | - | - | - | - | - | - | - | - |
| M R I Compatible I V Infusion Pumps | - | - | - | - | - | - | - | - | - | - | $3.37M | $2.46M | $3.50M | $2.67M | $2.15M | $1.88M | $2.66M | $4.54M | $4.77M | $4.55M |
| M R I Compatible Patient Vital Signs Monitoring Systems | - | - | - | - | - | - | - | - | - | - | $3.78M | $3.38M | - | - | - | - | - | - | - | - |
| Mri Compatible Patient Vital Signs Monitoring Systems | - | - | - | - | - | - | - | - | - | - | - | - | $2.60M | $2.93M | $2.28M | $1.93M | $2.89M | $3.49M | $2.56M | $1.89M |
IRadimed's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: MRI Compatible Patient Vital Signs Monitoring Systems (100.00%).
IRadimed Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $52.53M | $43.90M | - | - | - |
| International | $13.04M | - | - | - | - |
| United States | - | - | $33.46M | - | - |
| U | - | - | - | $24.54M | $30.93M |
IRadimed's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (80.12%), and International (19.88%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | $2.44M | $4.19M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $15.49M | $13.41M | $27.60M | $12.95M | $11.98M | $12.29M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| United States | - | - | - | - | - | - | $10.81M | $10.82M | $9.98M | $9.47M | - | - | - | - | - | - | - | - | - | - |
| U | - | - | - | - | - | - | - | - | - | - | $8.68M | $8.04M | $7.27M | $7.11M | $6.47M | $4.64M | $6.32M | $8.01M | $8.28M | $7.56M |
IRadimed's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (86.37%), and International (13.63%).
IRadimed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| CNMD | CONMED | $1.24B | $332.10M |
| LIVN | LivaNova | $1.15B | $318.60M |
| GKOS | Glaukos | $314.71M | $95.69M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| IRMD | IRadimed | $65.56M | $17.93M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| OSA | ProSomnus | $27.65M | $7.46M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
IRMD Revenue FAQ
What is IRadimed’s yearly revenue?
IRadimed's yearly revenue for 2023 was $65.56M, representing an increase of 23.00% compared to 2022. The company's yearly revenue for 2022 was $53.3M, representing an increase of 27.48% compared to 2021. IRMD's yearly revenue for 2021 was $41.81M, representing an increase of 31.83% compared to 2020.
What is IRadimed’s quarterly revenue?
IRadimed's quarterly revenue for Q2 2024 was $17.93M, a 1.88% increase from the previous quarter (Q1 2024), and a 11.15% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $17.6M, a 0.84% increase from the previous quarter (Q4 2023), and a 13.72% increase year-over-year (Q1 2023). IRMD's quarterly revenue for Q4 2023 was $17.45M, a 5.74% increase from the previous quarter (Q3 2023), and a 17.42% increase year-over-year (Q4 2022).
What is IRadimed’s revenue growth rate?
IRadimed's revenue growth rate for the last 3 years (2021-2023) was 56.79%, and for the last 5 years (2019-2023) was 70.22%.
What are IRadimed’s revenue streams?
IRadimed's revenue streams in c 23 are MRI Compatible Patient Vital Signs Monitoring Systems
What is IRadimed’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of IRadimed was MRI Compatible Patient Vital Signs Monitoring Systems. This segment made a revenue of $25.41M, representing 100.00% of the company's total revenue.